| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 2.494.901.693 $ | +593.926.860 $ | +221,9 % | 14 | 1.717.873.740 $ | +620.296.946 $ | +62,3 % | 7 | 934.085.409 $ | +704.223.046 $ | +369,0 % | 4 | ||||
| Abivax S.A. | ABVX | → 0 | Schwach | 721.668.815 $ | -237.365.464 $ | -24,8 % | 1 | 959.034.279 $ | +355.259.779 $ | +58,8 % | 1 | 603.774.500 $ | +557.441.541 $ | +1.203,1 % | 1 |
| CG Oncology, Inc. | CGON | → 0 | Neutral | 248.399.542 $ | +96.012.589 $ | +63,0 % | 1 | 152.386.953 $ | +4.551.055 $ | +3,1 % | 1 | 147.835.898 $ | +52.410.542 $ | +54,9 % | 1 |
| Tango Therapeutics, Inc. | TNGX | → 0 | Neutral | 220.310.005 $ | +107.237.852 $ | +94,8 % | 1 | 113.072.153 $ | +41.368.107 $ | +57,7 % | 1 | ||||
| Cogent Biosciences, Inc. | COGT | → 0 | Neutral | 190.405.950 $ | -18.031.164 $ | -8,7 % | 1 | 208.437.114 $ | +110.815.508 $ | +113,5 % | 1 | 97.621.606 $ | +47.617.393 $ | +95,2 % | 1 |
| Centessa Pharmaceuticals plc | CNTA | → 0 | 170.258.986 $ | +63.054.121 $ | +58,8 % | 1 | 107.204.865 $ | +31.145.225 $ | +40,9 % | 1 | |||||
| Dianthus Therapeutics, Inc. /DE/ | DNTH | → 0 | Neutral | 140.702.286 $ | +71.608.611 $ | +103,6 % | 1 | ||||||||
| Tyra Biosciences, Inc. | TYRA | → 0 | Schwach | 124.435.934 $ | +48.244.806 $ | +63,3 % | 1 | ||||||||
| Immunovant, Inc. | IMVT | → 0 | Schwach | 110.736.422 $ | +68.515.505 $ | +162,3 % | 1 | ||||||||
| BIOCRYST PHARMACEUTICALS INC | BCRX | → 0 | Stark | 104.919.615 $ | +104.919.615 $ | 1 | |||||||||
| Mirum Pharmaceuticals, Inc. | MIRM | → 0 | Neutral | 98.112.087 $ | +93.210.836 $ | +1.901,8 % | 1 | ||||||||
| Vor Biopharma Inc. | VOR | → 0 | Schwach | 96.499.052 $ | +96.499.052 $ | 1 | |||||||||
| Spyre Therapeutics, Inc. | SYRE | → 0 | Schwach | 95.865.356 $ | +33.602.290 $ | +54,0 % | 1 | ||||||||
| Dyne Therapeutics, Inc. | DYN | → 0 | Neutral | 90.272.217 $ | +31.890.645 $ | +54,6 % | 1 | ||||||||
| RAPT Therapeutics, Inc. | RAPT | → 0 | 87.466.159 $ | +45.266.627 $ | +107,3 % | 1 | |||||||||
| Amylyx Pharmaceuticals, Inc. | AMLX | → 0 | Schwach | 86.788.987 $ | +11.363.738 $ | +15,1 % | 1 | 84.853.405 $ | +46.753.570 $ | +122,7 % | 1 | ||||
| Disc Medicine, Inc. | IRON | → 0 | Schwach | 85.798.656 $ | +55.054.473 $ | +179,1 % | 1 | ||||||||
| 2.494.901.693 $ | +593.926.860 $ | +221,9 % | 14 | 1.717.873.740 $ | +620.296.946 $ | +62,3 % | 7 | 934.085.409 $ | +704.223.046 $ | +369,0 % | 4 | ||||